Regenxbio (RGNX) Reports Q3 Loss of $1.52/Share

Regenxbio (NASDAQ: RGNX) reported Q3 EPS of ($1.52), versus ($0.73) reported last year. Revenue for the quarter came in at $1.1 million, versus $500 thousand reported last year.

For earnings history and earnings-related data on Regenxbio (RGNX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• BIG3 Basketball to go public via Graf Global merger at $290 million
• Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital